| Dr Shannon Alayna Bey, MD | |
|
100 The American Rd, Morris Plains, NJ 07950-2443 | |
| (973) 867-7334 | |
| Not Available |
| Full Name | Dr Shannon Alayna Bey |
|---|---|
| Gender | Female |
| Speciality | Pathology |
| Experience | 13 Years |
| Location | 100 The American Rd, Morris Plains, New Jersey |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235425919 | NPI | - | NPPES |
| 103130333 | Medicaid | PA |
| Facility Name | Location | Facility Type |
|---|---|---|
| Morristown Medical Center | Morristown, NJ | Hospital |
| Overlook Medical Center | Summit, NJ | Hospital |
| Newton Medical Center | Newton, NJ | Hospital |
| Chilton Medical Center | Pompton plains, NJ | Hospital |
| Hackettstown Medical Center | Hackettstown, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Morristown Pathology Associates Pa | 4981699717 | 29 |
News Archive
Scientists who developed a technology for identifying and targeting unique protein receptor ZIP Codes on the cellular surface have found a way to penetrate the outer membrane and deliver engineered particles - called iPhage - to organelles inside the cell.
Congress Daily: The federal government added 1,000 companies to the "early retiree benefit program established under the healthcare overhaul law, bringing the total number of companies participating to 3,000. The $5 billion program is a stopgap measure meant to help cover retired Americans over the age of 55 who are not eligible for Medicare."
Asterias Biotherapeutics, Inc., a biotechnology company focused on the emerging field of regenerative medicine, today announced that it has been added to the Russell 2000, Russell 3000, Russell Global and Russell Microcap indexes following Russell Investments' ("Russell") reconstitution of its comprehensive set of U.S. and global equity indexes after the close of the U.S. markets on June 26, 2015.
Numerate, Inc. announced today that it has been awarded a new three-year contract by the Defense Threat Reduction Agency (DTRA), an agency within the U.S. Department of Defense, to adapt its pioneering small-molecule drug design platform to the rapid design and optimization of drugs against biowarfare agents.
Scientists at the HudsonAlpha Institute for Biotechnology, the University of California, San Francisco (UCSF), and the University of Alabama at Birmingham (UAB), have identified a new risk factor for multiple neurodegenerative diseases.
› Verified 7 days ago
| Entity Name | Morristown Pathology Associates Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922075886 PECOS PAC ID: 4981699717 Enrollment ID: O20040420000045 |
News Archive
Scientists who developed a technology for identifying and targeting unique protein receptor ZIP Codes on the cellular surface have found a way to penetrate the outer membrane and deliver engineered particles - called iPhage - to organelles inside the cell.
Congress Daily: The federal government added 1,000 companies to the "early retiree benefit program established under the healthcare overhaul law, bringing the total number of companies participating to 3,000. The $5 billion program is a stopgap measure meant to help cover retired Americans over the age of 55 who are not eligible for Medicare."
Asterias Biotherapeutics, Inc., a biotechnology company focused on the emerging field of regenerative medicine, today announced that it has been added to the Russell 2000, Russell 3000, Russell Global and Russell Microcap indexes following Russell Investments' ("Russell") reconstitution of its comprehensive set of U.S. and global equity indexes after the close of the U.S. markets on June 26, 2015.
Numerate, Inc. announced today that it has been awarded a new three-year contract by the Defense Threat Reduction Agency (DTRA), an agency within the U.S. Department of Defense, to adapt its pioneering small-molecule drug design platform to the rapid design and optimization of drugs against biowarfare agents.
Scientists at the HudsonAlpha Institute for Biotechnology, the University of California, San Francisco (UCSF), and the University of Alabama at Birmingham (UAB), have identified a new risk factor for multiple neurodegenerative diseases.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Shannon Alayna Bey, MD 100 The American Rd, Morris Plains, NJ 07950-2443 Ph: (412) 858-2560 | Dr Shannon Alayna Bey, MD 100 The American Rd, Morris Plains, NJ 07950-2443 Ph: (973) 867-7334 |
News Archive
Scientists who developed a technology for identifying and targeting unique protein receptor ZIP Codes on the cellular surface have found a way to penetrate the outer membrane and deliver engineered particles - called iPhage - to organelles inside the cell.
Congress Daily: The federal government added 1,000 companies to the "early retiree benefit program established under the healthcare overhaul law, bringing the total number of companies participating to 3,000. The $5 billion program is a stopgap measure meant to help cover retired Americans over the age of 55 who are not eligible for Medicare."
Asterias Biotherapeutics, Inc., a biotechnology company focused on the emerging field of regenerative medicine, today announced that it has been added to the Russell 2000, Russell 3000, Russell Global and Russell Microcap indexes following Russell Investments' ("Russell") reconstitution of its comprehensive set of U.S. and global equity indexes after the close of the U.S. markets on June 26, 2015.
Numerate, Inc. announced today that it has been awarded a new three-year contract by the Defense Threat Reduction Agency (DTRA), an agency within the U.S. Department of Defense, to adapt its pioneering small-molecule drug design platform to the rapid design and optimization of drugs against biowarfare agents.
Scientists at the HudsonAlpha Institute for Biotechnology, the University of California, San Francisco (UCSF), and the University of Alabama at Birmingham (UAB), have identified a new risk factor for multiple neurodegenerative diseases.
› Verified 7 days ago
Angel Enrique De Dios Quintero, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 100 The American Rd, Morris Plains, NJ 07950 Phone: 973-867-7349 |